SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin informs about press release

16 Oct 2018 Evaluate

Lupin has informed about press release titled ‘Survey Data Reveals the Need for Improved Communication Between Patients and Healthcare Providers About Bacterial Vaginosis (BV), the Most Common Gynecologic Infection in the US.’

The above information is a part of company’s filings submitted to BSE.

 

Lupin Share Price

2326.80 2.55 (0.11%)
20-Apr-2026 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.00
Dr. Reddys Lab 1226.10
Cipla 1228.55
Zydus Lifesciences 935.00
Lupin 2326.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×